Clinical Trial Update: Additive Anti-inflammatory Action for Aortopathy & Arteriopathy

View source ↗

Summary

A new clinical trial from Nanjing Medical University is recruiting to evaluate additive anti-inflammatory action for treating acute aortic syndrome (aortopathy/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Syndrome

Snippet

Sponsor: Nanjing Medical University | Conditions: Acute Aortic Syndrome | Status: RECRUITING